Status:
UNKNOWN
Clinical Study of Adipose Derived Mesenchymal Stem Cells for Treatment of Pulmonary Arterial Hypertension
Lead Sponsor:
Liaocheng People's Hospital
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
40-75 years
Phase:
PHASE1
PHASE2
Brief Summary
Pulmonary arterial hypertension is a disease characterised by pathological changes in the pulmonary arteries leading to a progressive increase in pulmonary vascular resistance and pulmonary artery pre...
Eligibility Criteria
Inclusion
- （1）40-75years （2）Male or female （3）The patients that COPD with moderate to severe pulmonary hypertension (pulmonary systolic pressure more than 40mmHg)in relatively stable period （4）To preliminary assess the Patients'lifetime have more than 6 months （5）According to the researchers' judgment, they can abide by the research protocol or Volunteer to participate in the clinical study, understand the study procedure and sign the informed consent in person.
- \-
Exclusion
- Patients with acute myocardial infarction and cardiac surgery in the past 1 month
- Surgery may be required within 8 weeks
- patients with prior pneumonectomy or having acute, chronic pulmonary embolism or other serious pulmonary diseases
- Having a history of malignant tumor
- Participated in other clinical investigators in the last 6 months
- To allergic to penicillin, gentamicin, aminoglycoside, human serum albumin and DMEM medium
- A woman who is planning to pregnancy, gestation, or lactation
- Other reasons caused Pulmonary hypertension and heart failure caused by other causes;Severe liver and kidney failure;Autoimmune diseases;Patients with infectious diseases
- According toThe researchers' judgments, there are concomitant diseases that seriously endanger the safety of the subjects or affect the completion of the study
- According to the researcher's judgment, this study is not suitable for other conditions -
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04055415
Start Date
August 1 2019
End Date
February 1 2021
Last Update
August 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Liaocheng city people's hospital
Liaocheng, Shandong, China, 0635